Clinical Neurosurgery

Epilepsy Surgery Indications

Epilepsy Surgery Indications

What Do You Need to Know?

  • Drug-resistant epilepsy = failure of 2 appropriate ASMs at adequate doses (ILAE definition); refer early — do NOT wait for 5+ ASM failures
  • Best surgical candidates: focal onset seizures with an identifiable MRI lesion and concordant presurgical data
  • ERSET trial: early surgery for mTLE = 73% seizure-free vs. 0% with continued medical therapy — surgery is superior, not a last resort
  • Temporal lobectomy is the most common and most successful epilepsy surgery; 60–80% Engel I for MTLE with hippocampal sclerosis
  • Presurgical workup: Phase I (video-EEG, MRI epilepsy protocol, PET, neuropsych) → Phase II (SEEG or grids) if non-concordant
  • Palliative options: corpus callosotomy for drop attacks (LGS); hemispherotomy for hemispheric epilepsy syndromes (Rasmussen, Sturge-Weber)
  • Engel classification: Class I = seizure-free (Ia = completely free, Ib = auras only); the standard outcome measure for epilepsy surgery
Surgical Candidacy — When to Refer

Drug-Resistant Epilepsy (ILAE Definition)

  • Definition: failure to achieve sustained seizure freedom after adequate trials of 2 tolerated, appropriately chosen ASMs (monotherapy or combination)
  • After 2 ASM failures, probability of seizure freedom with each additional agent drops to ~5%
  • Refer to a comprehensive epilepsy center as soon as drug resistance is established
  • Average delay from drug resistance to surgery referral is 10–20 years — this is unacceptable given Level 1 evidence

Landmark Trials Supporting Early Surgery

Trial Year Design Key Result
Wiebe et al. 2001 (NEJM) RCT: ATL vs. medical therapy for TLE 58% vs. 8% seizure-free at 1 year; NNT = 1.6
ERSET 2012 (JAMA) RCT: early surgery vs. continued medical therapy 73% vs. 0% seizure-free at 2 years
  • NNT of 1.6 (Wiebe) is among the largest treatment effects in clinical neurology
  • Earlier surgery → better cognitive outcomes, better psychosocial functioning, lower SUDEP risk

Ideal Candidates

  • Focal onset seizures with an identifiable epileptogenic focus
  • MRI-visible lesion (hippocampal sclerosis, FCD, low-grade tumor, cavernoma)
  • Concordance across all presurgical modalities (EEG, MRI, PET, semiology, neuropsych)
  • mTLE with hippocampal sclerosis = the “ideal” surgical candidate

Relative & Absolute Contraindications

Contraindication Type Notes
Primary generalized epilepsy Absolute (for resective surgery) May still be considered for palliative procedures (callosotomy, VNS)
Progressive/degenerative cause Absolute Neurodegenerative or metabolic etiologies with diffuse involvement
Bilateral independent foci Relative May proceed if one focus is clearly dominant or if palliative surgery is planned
Focus in eloquent cortex Relative Cortical mapping (SEEG, fMRI) needed; consider neuromodulation (RNS) as alternative
Severe psychiatric comorbidity Relative Active psychosis or suicidality may need stabilization first; not absolute

Board Pearls

  • Drug-resistant epilepsy = failure of 2 ASMs (not 3, not 5) — boards test this ILAE threshold repeatedly
  • After 2 ASM failures, each additional agent adds only ~5% chance of seizure freedom — surgery should be discussed, not deferred
  • Primary generalized epilepsy is NOT a candidate for resective surgery but may benefit from callosotomy or neuromodulation
Presurgical Evaluation — The Neurology Perspective

Phase I (Noninvasive)

Modality What It Shows Key Points
Video-EEG monitoring Seizure-onset zone, semiology, interictal discharges Gold standard; capture ≥3–5 habitual seizures; typically 5–14 day admission
3T MRI (epilepsy protocol) Structural lesion (HS, FCD, tumors, cavernomas) NOT a “routine brain MRI”; includes 3D T1/FLAIR, coronal T2 perpendicular to hippocampus, SWI
FDG-PET Interictal hypometabolism at epileptogenic zone 80–90% sensitivity for mTLE; more sensitive than MRI for subtle lesions
Ictal SPECT (SISCOM) Ictal hyperperfusion at seizure-onset zone Must inject within 30 sec of seizure onset; >45 sec = propagation, not onset
MEG / MSI Magnetic source imaging of interictal discharges Most useful in MRI-negative cases; detects sulcal cortex better than EEG
Neuropsychological testing Baseline cognition; lateralization of language/memory Verbal memory deficit → left temporal; visuospatial → right temporal

Phase II (Invasive Monitoring)

  • Indications: non-concordant Phase I data, MRI-negative cases, seizure onset near eloquent cortex, bilateral independent onsets
  • Required in 30–40% of surgical candidates

SEEG vs. Subdural Grids

Feature SEEG (Stereo-EEG) Subdural Grids
Implantation Stereotactic via twist-drill holes; robot-assisted Open craniotomy
Spatial coverage Deep structures (hippocampus, insula, cingulate); bilateral feasible Cortical surface; limited deep access
Complications Hemorrhage 1–4%; infection 1–2% Overall 10–15% (hemorrhage, infection, edema)
Cortical mapping Limited by electrode geometry Excellent for motor/language mapping
Current trend Has largely replaced grids in North America Declining; reserved for specific cortical mapping needs

Language & Memory Lateralization

  • fMRI: has replaced the Wada test for language lateralization (>90% concordance); noninvasive, widely available
  • Wada test (intracarotid amobarbital): still needed for memory lateralization, especially before dominant temporal resection
  • Left hemisphere = language dominant in 95% of right-handers, ~70% of left-handers

The Concordance Principle

  • All modalities must point to the same focus — this is the fundamental principle of presurgical evaluation
  • Full concordance (semiology + EEG + MRI + PET + neuropsych) → >70% seizure-free outcome
  • Discordance → need Phase II investigation or may not be a surgical candidate
  • Final decision made at multidisciplinary epilepsy surgery conference

Board Pearls

  • FDG-PET = interictal HYPOmetabolism; Ictal SPECT = ictal HYPERperfusion — opposite findings, both localizing the epileptogenic zone
  • fMRI replaces Wada for language; Wada still needed for memory lateralization (especially left TLE)
  • SEEG has replaced subdural grids at most centers: lower complications, better deep structure access, bilateral sampling
Temporal Lobectomy

Overview

  • Most common and most successful epilepsy surgery worldwide
  • Standard procedure for mesial temporal lobe epilepsy (mTLE) with hippocampal sclerosis
  • Engel I outcome: 60–80% for mTLE-HS at 1 year; 40–55% without HS

Anterior Temporal Lobectomy (ATL)

  • Standard open approach: resects anterior temporal neocortex + mesial structures (amygdala, hippocampus, parahippocampal gyrus)
  • Resection extent — dominant hemisphere: 3.5–4.5 cm from temporal pole
  • Resection extent — nondominant hemisphere: 5–6 cm from temporal pole
  • Highest seizure-free rates among all surgical approaches for mTLE

Selective Amygdalohippocampectomy (SAH)

  • Targets only mesial structures while preserving lateral temporal neocortex
  • Engel I: 55–65% — slightly lower than standard ATL
  • Better cognitive preservation: naming and verbal memory decline less than ATL
  • Preferred when cognitive preservation is a priority, especially dominant hemisphere

Complications of Temporal Resection

Complication Incidence Mechanism
Superior quadrantanopia ~18% Disruption of Meyer loop (optic radiation in temporal lobe)
Verbal memory decline Up to 44% (left ATL) Dominant mesial temporal resection; worse with strong preop memory
Naming difficulty 34% (dominant side) Lateral temporal neocortex resection
De novo psychiatric symptoms 10–20% Depression, anxiety; “burden of normality”
Major permanent deficit 4.7% Hemiparesis, hemianopia
Mortality <0.6% All epilepsy surgeries combined

Board Pearls

  • Superior quadrantanopia (“pie in the sky”) = classic visual field cut from temporal lobectomy due to Meyer loop disruption
  • Left ATL carries highest cognitive risk: verbal memory decline up to 44%, naming decline 34%
  • Dominant ATL resection limit = 3.5–4.5 cm; nondominant = 5–6 cm from temporal pole — boards test this
Lesionectomy

Principle

  • Resection of a discrete epileptogenic lesion + surrounding epileptogenic zone
  • Complete resection = the single strongest predictor of seizure freedom regardless of pathology

Outcomes by Pathology

Pathology Engel I Rate Key Considerations
Low-grade tumors (ganglioglioma, DNET) 75–90% Best outcomes; gross total resection is critical
Cavernous malformations 70–80% Resect surrounding hemosiderin ring; ECoG-guided resection improves outcomes
FCD Type IIb 70–80% Best outcomes among FCD subtypes; transmantle sign on MRI; FCD II overall 50–70%
Hippocampal sclerosis 60–70% Standard ATL or SAH; concordant data critical
MRI-negative 30–45% Least favorable; requires Phase II (SEEG); advanced MRI postprocessing may reveal subtle FCD

FCD Type II — Why Outcomes Are Excellent

  • Well-defined margins (especially IIb with balloon cells)
  • Transmantle sign on MRI aids complete resection
  • FCD IIb > FCD IIa > FCD I for seizure-free outcomes
  • Incomplete resection is the primary cause of surgical failure

Clinical Pearl

When evaluating a patient with a brain lesion and epilepsy, remember that the epileptogenic zone may extend beyond the visible lesion. ECoG (intraoperative electrocorticography) can guide resection margins. Complete resection of both the lesion and the surrounding epileptogenic cortex → best outcomes.

Corpus Callosotomy

Indications

  • Primary indication: disabling drop attacks (tonic, atonic seizures) refractory to medical therapy
  • Lennox-Gastaut syndrome (LGS) is the most common indication
  • Palliative procedure — does NOT cure epilepsy; reduces frequency/severity of the most disabling seizure type
  • Not for focal resectable epilepsy; reserved for generalized or multifocal epilepsy

Surgical Approach

  • Staged approach preferred: anterior 2/3 callosotomy first
  • If drop attacks persist → complete callosotomy (higher efficacy but higher morbidity)
  • Anterior 2/3 disrupts the primary pathways for bilateral seizure propagation causing drop attacks

Outcomes

  • Eliminates drop attacks: ~55% of patients
  • Complete seizure freedom: only 19%
  • Better outcomes with: infantile spasms history, shorter epilepsy duration, complete callosotomy

Disconnection Syndrome

  • Alien hand syndrome: hand acts independently of will; more common with complete callosotomy
  • Split-brain effects: interhemispheric transfer deficits — cannot name objects placed in left hand, bimanual coordination problems
  • Transient postop deficits: leg weakness, akinesia, mutism (medial frontal retraction) — usually resolve in days to weeks
  • Risk significantly higher with complete callosotomy → supports staged approach

Board Pearls

  • Corpus callosotomy = the board answer for disabling drop attacks in LGS
  • Staged approach: anterior 2/3 first, then complete if needed
  • Alien hand syndrome = classic board complication of complete callosotomy
  • It is a palliative procedure — does NOT make patients seizure-free
Hemispheric Surgery

Indications

Condition Key Features Notes
Rasmussen encephalitis Progressive unilateral encephalitis; epilepsia partialis continua Hemispherotomy is the definitive treatment; immunotherapy does not cure
Sturge-Weber syndrome Hemispheric leptomeningeal angiomatosis Consider early surgery for refractory seizures
Hemimegalencephaly Unilateral hemispheric enlargement with cortical malformation Early surgery; often presents in infancy
Large hemispheric FCD Extensive unilateral cortical dysplasia When the entire hemisphere is involved or multiple lobes affected
Perinatal stroke Large unilateral infarction with resultant epilepsy Preexisting hemiparesis; good plasticity potential

Hemispherectomy vs. Hemispherotomy

  • Anatomic hemispherectomy: complete hemisphere removal — historical; associated with late complications (superficial hemosiderosis, hydrocephalus)
  • Functional hemispherotomy: preferred modern technique — disconnects hemisphere while preserving most cortex in situ
  • Techniques: vertical parasagittal, periinsular, endoscopic-assisted
  • Hemispherotomy has equivalent seizure outcomes with less morbidity than anatomic hemispherectomy

Outcomes

  • 73% seizure-free in children at last follow-up
  • Best outcomes in younger children (greater neuroplasticity for functional reorganization)
  • Most candidates already have preexisting contralateral hemiparesis and hemianopia

Expected Deficits

  • Contralateral hemiparesis: most already have preoperative hemiparesis; upper extremity typically more affected
  • Homonymous hemianopia: expected and accepted
  • Language: children with early-onset hemispheric pathology have significant language reorganization to the contralateral hemisphere
  • Complications: hydrocephalus requiring shunt (10–20%), hemorrhage, aseptic meningitis

Board Pearls

  • Rasmussen encephalitis → hemispherotomy = the definitive treatment; do not delay for immunotherapy
  • Functional hemispherotomy is preferred over anatomic hemispherectomy (equivalent seizure outcomes, less morbidity)
  • 73% seizure-free in children; best outcomes in younger patients due to neuroplasticity
Engel Outcome Classification
Engel Class Outcome Subclasses
Class I Free of disabling seizures Ia = completely seizure-free; Ib = auras only; Ic = some seizures postop but seizure-free ≥2 years; Id = generalized seizures only with ASM withdrawal
Class II Rare disabling seizures Almost seizure-free; rare seizures after initial complete control
Class III Worthwhile improvement Meaningful seizure reduction but ongoing disabling seizures
Class IV No worthwhile improvement No significant change or worsening of seizures

Board Pearls

  • Engel Ia = completely seizure-free (the goal of surgery)
  • Engel Ib = auras only — still classified as “free of disabling seizures”; boards may present a patient with only auras and ask you to classify — this is Class Ib, NOT Class II
  • Engel classification is the standard outcome measure for epilepsy surgery across all clinical trials
Surgery Types by Indication — Summary
Surgery Type Primary Indication Engel I Rate Key Notes
ATL mTLE with hippocampal sclerosis 60–70% Most common epilepsy surgery; Level 1 RCT evidence
SAH mTLE (cognitive preservation priority) 55–65% Preserves lateral temporal neocortex; better naming
Lesionectomy FCD, cavernomas, low-grade tumors 50–90% Outcomes depend on pathology and completeness of resection
Corpus callosotomy Drop attacks in LGS 19% (55% drop-free) Palliative; staged anterior 2/3 first
Hemispherotomy Rasmussen, Sturge-Weber, hemimegalencephaly 73% (children) Functional disconnection preferred over anatomic removal
LITT / SLAH mTLE (minimally invasive alternative) 55–60% MRI-guided laser ablation; 1–2 day hospital stay

Clinical Pearl

When discussing epilepsy surgery with patients, present the trade-off between seizure-free rates and invasiveness: ATL has the highest seizure-free rates for mTLE but greatest cognitive risk; SAH and LITT offer better cognitive preservation at modestly lower seizure-free rates. LITT does not “burn bridges” — open ATL remains fully feasible after failed LITT.

Temporal Lobectomy Outcomes — Comparison Table
Feature ATL SAH LITT/SLAH
Engel I at 1 year 60–70% 55–65% 55–60%
Approach Open craniotomy Open craniotomy 3.2 mm burr hole (MRI-guided)
Hospital stay 3–5 days 3–5 days 1–2 days
Naming decline (dominant) 34% Lower than ATL Lowest risk
Verbal memory decline (left) Up to 44% Better than ATL Best preservation
Visual field defect ~18% Variable by approach 8.8%
Recovery time 4–6 weeks 4–6 weeks 1–2 weeks
Salvage after failure Limited ATL possible ATL fully feasible

Board Pearls

  • Drug-resistant epilepsy = failure of 2 ASMs — refer for surgery evaluation immediately; do NOT wait years
  • Temporal lobectomy for mTLE-HS: 60–80% Engel I; NNT = 1.6 (Wiebe 2001); ERSET = 73% vs. 0%
  • Superior quadrantanopia = Meyer loop disruption = classic visual field cut of temporal lobectomy
  • Left ATL: verbal memory decline up to 44%, naming decline 34% — highest cognitive risk
  • Lesionectomy outcome hierarchy: ganglioglioma/DNET (75–90%) > cavernoma (70–80%) > FCD IIb (70–80%) > HS (60–70%) > MRI-negative (30–45%)
  • Corpus callosotomy = drop attacks in LGS; staged anterior 2/3 first; alien hand syndrome = classic complication of complete callosotomy
  • Rasmussen encephalitis → hemispherotomy is the definitive treatment; functional hemispherotomy preferred over anatomic hemispherectomy
  • Engel Ib = auras only = still “free of disabling seizures”; do NOT classify as Class II

Clinical Pearl

Cross-reference: Detailed epilepsy surgery content including ATL, SAH, LITT, lesionectomy, callosotomy, hemispherotomy, long-term outcomes, and ASM management post-surgery is covered in depth in the Epilepsy specialty section (Epilepsy Surgery and Presurgical Evaluation topics). This note focuses on surgical indications from the neurosurgical referral perspective.